Label: WESCAP-PN DHA- ascorbic acid, cholecalciferol, .alpha.-tocopherol, d-, pyridoxine hydrochloride, levomefolate calcium, folic acid, cyanocobalamin, calcium carbonate, ferrous fumarate, magnesium oxide, and doconexent capsule, gelatin coated

  • NHRIC Code(s): 69367-316-30
  • Packager: Westminster Pharmaceuticals, LLC
  • Category: DIETARY SUPPLEMENT
  • DEA Schedule: None
  • Marketing Status: Dietary Supplement

Drug Label Information

Updated December 17, 2021

If you are a consumer or patient please visit this version.

View All Sections
  • STATEMENT OF IDENTITY

    Supplement Facts
    Serving Size: 1 Softgel
    Amount Per Serving% Daily Value for Pregnant and Lactating Women
    *
    From at least 330 mg purified fish oil
    †
    Daily Value not established
    Vitamin C (ascorbic Acid)85 mg71%
    Vitamin D (Vitamin D3 as Cholecalciferol)5 mcg (200 IU)33%
    Vitamin E (d-alpha tocopherol)6.7 mg (10 IU)35%
    Vitamin B6 (pyridoxine HCl)25 mg1250%
    Folate (L-Methylfolate Calcium, or 6(S)-5-MTHF-Ca 600 mcg) (folic acid, USP 400 mcg)1700 mcg DFE (400 mcg Folic Acid)283%
    Vitamin B12 (cyanocobalamin)12 mcg429%
    Calcium (calcium carbonate)140 mg11%
    Iron (ferrous fumarate)27 mg100%
    Magnesium (magnesium oxide)45 mg11%
    Docosahexaenoic Acid (DHA)300 mg*†

    Other Ingredients: Gelatin, Soybean Oil, Glycerin, Purified Water, Soy Lecithin, Titanium Dioxide, Yellow Beeswax, Natural Creamy Orange Flavor, FD&C Yellow #6, Ethyl Vanillin, FD&C Red #40.

  • DESCRIPTION

    WesCap-PN DHA is a prescription prenatal/postnatal multivitamin/mineral dietary supplement with fishbased DHA and should be administered under the supervision of a licensed medical practitioner.

  • DOSAGE AND ADMINISTRATION

    Before, during and/or after pregnancy, one softgel daily or as directed by a licensed healthcare practitioner regardless of lactation status.

  • CAUTION

    Ingestion of more than 3 grams per day of omega-3 fatty acids (ALA, EPA, and DHA) may have potential antithrombotic activities, or effects, and may increase bleeding times. Administration of omega-3 fatty acids, including DHA, should be avoided in patients with inherited or acquired bleeding diathesis, including those taking anticoagulants. Exercise caution to ensure that the prescribed dosage of DHA does not exceed 1 gram (1000 mg) per day.

  • WARNINGS

    WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.
  • CAUTION

    High levels of folic acid may, especially in older adults, hide signs of Vitamin B-12 deficiency (such as pernicious anemia), a condition that can cause nerve damage.

  • STORAGE

    Store at 20° to 25°C (68° to 77°F). Excursions permitted to 15° to 30°C (59° to 86°F). Protect from light and moisture. Dispense in a tight, light-resistant container.

  • HEALTH CLAIM

    Call your licensed medical practitioner about side effects. You may report side effects by calling Westminster Pharmaceuticals LLC, at 1-844-221-7294 or FDA AT 1-800-FDA-1088.

  • HOW SUPPLIED

    Supplied as oblong, orange-colored softgel, imprinted "316" and dispensed in 30 count bottles.

  • HEALTH CLAIM

    Manufactured for:
    Westminster Pharmaceuticals, LLC
    Nashville, TN 37217
    Rev. 09/21

  • PRINCIPAL DISPLAY PANEL - 30 Softgel Bottle Label

    69367-316-30
    Rx

    WesCap-PN DHA

    PRENATAL/POSTNATAL

    Prescription Multivitamin/Mineral
    Dietary Supplement with
    Fish-Based DHA

    30 Softgels

    Westminster
    Pharmaceuticals

    PRINCIPAL DISPLAY PANEL - 30 Softgel Bottle Label
  • INGREDIENTS AND APPEARANCE
    WESCAP-PN DHA 
    ascorbic acid, cholecalciferol, .alpha.-tocopherol, d-, pyridoxine hydrochloride, levomefolate calcium, folic acid, cyanocobalamin, calcium carbonate, ferrous fumarate, magnesium oxide, and doconexent capsule, gelatin coated
    Product Information
    Product TypeDIETARY SUPPLEMENTItem Code (Source)NHRIC:69367-316
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    ASCORBIC ACID (UNII: PQ6CK8PD0R) (ASCORBIC ACID - UNII:PQ6CK8PD0R) ASCORBIC ACID85 mg
    CHOLECALCIFEROL (UNII: 1C6V77QF41) (CHOLECALCIFEROL - UNII:1C6V77QF41) CHOLECALCIFEROL200 [iU]
    .ALPHA.-TOCOPHEROL, D- (UNII: N9PR3490H9) (.ALPHA.-TOCOPHEROL, D- - UNII:N9PR3490H9) .ALPHA.-TOCOPHEROL, D-10 [iU]
    PYRIDOXINE HYDROCHLORIDE (UNII: 68Y4CF58BV) (PYRIDOXINE - UNII:KV2JZ1BI6Z) PYRIDOXINE25 mg
    LEVOMEFOLATE CALCIUM (UNII: A9R10K3F2F) (LEVOMEFOLIC ACID - UNII:8S95DH25XC) LEVOMEFOLIC ACID600 ug
    FOLIC ACID (UNII: 935E97BOY8) (FOLIC ACID - UNII:935E97BOY8) FOLIC ACID400 ug
    CYANOCOBALAMIN (UNII: P6YC3EG204) (CYANOCOBALAMIN - UNII:P6YC3EG204) CYANOCOBALAMIN12 ug
    CALCIUM CARBONATE (UNII: H0G9379FGK) (CALCIUM CATION - UNII:2M83C4R6ZB) CALCIUM CATION140 mg
    FERROUS FUMARATE (UNII: R5L488RY0Q) (FERROUS CATION - UNII:GW89581OWR) FERROUS CATION27 mg
    MAGNESIUM OXIDE (UNII: 3A3U0GI71G) (MAGNESIUM CATION - UNII:T6V3LHY838) MAGNESIUM CATION45 mg
    DOCONEXENT (UNII: ZAD9OKH9JC) (DOCONEXENT - UNII:ZAD9OKH9JC) DOCONEXENT300 mg
    Inactive Ingredients
    Ingredient NameStrength
    YELLOW WAX (UNII: 2ZA36H0S2V)  
    SOYBEAN OIL (UNII: 241ATL177A)  
    GELATIN, UNSPECIFIED (UNII: 2G86QN327L)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    WATER (UNII: 059QF0KO0R)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    LECITHIN, SOYBEAN (UNII: 1DI56QDM62)  
    ETHYL VANILLATE (UNII: V38JK4Z93O)  
    FD&C RED NO. 40 (UNII: WZB9127XOA)  
    FD&C YELLOW NO. 6 (UNII: H77VEI93A8)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NHRIC:69367-316-3030 in 1 BOTTLE, PLASTIC
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    DIETARY SUPPLEMENT12/14/2021
    Supplement Facts
    Serving Size : Serving per Container :
    Amount Per Serving% Daily Value
    color
    scoring1
    shape
    size (solid drugs)13 mm
    imprint
    Labeler - Westminster Pharmaceuticals, LLC (079516651)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!